No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
315 |
4. Check minimum number of eventsNone |
315 |
5. Include endpointsNone |
315 |
6. Filter based on genotype QC (FinnGen only) |
315 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E34
- Name in latin
- Syndroma carcinoides
Similar endpoints
↥List of similar endpoints to
Carcinoid syndrome
based on the number of shared cases.
Similar with more cases:
- Other endocrine disorders
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1609 | 854 | 744 |
| Only index persons | 1230 | 666 | 564 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 64.12 | 63.82 | 64.35 |
| Only index persons | 62.75 | 62.30 | 63.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 315 | 152 | 163 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 62.00 | 60.32 | 63.57 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 292
- Matched controls
- 2918
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
323.0
276
*
H01CB02
ATC
octreotide; parenteral
1907.0
129.4
116
*
130
Kela drug reimbursment
Malignant tumour
31.2
126.0
184
151
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
892.3
122.7
112
*
H01CB03
ATC
lanreotide; parenteral
417.5
92.5
88
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
46.8
73.2
89
27
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
463.5
73.1
70
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
428.0
68.6
66
*
JFB00
NOMESCO Finland
Partial resection of small intestine
64.4
63.9
73
15
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
29.7
63.8
87
41
JN4BD
NOMESCO Finland
Extensive body CT
11.5
63.3
136
205
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
23.3
55.8
82
48
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
329.7
55.2
54
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
322.3
54.1
53
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
10.2
52.4
117
179
JN4CD
NOMESCO Finland
Very extensive body CT
14.3
48.5
87
84
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
539.8
47.8
46
*
JN4AD
NOMESCO Finland
Body CT examination
10.3
42.9
92
125
D77
ICPC
Malignant digestive neopl other/NOS
129.0
42.0
44
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
167.3
42.0
43
*
L01AX03
ATC
temozolomide; systemic
162.8
40.9
42
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
73.6
39.4
44
7
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
39.6
35.2
44
13
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
35.2
35.1
45
15
302
Kela drug reimbursment
Interferon alfa
+∞
34.0
32
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
33.3
127
370
JFB30
NOMESCO Finland
Right hemicolectomy
26.3
28.3
39
17
L03AB05
ATC
interferon alfa-2b; parenteral
111.1
28.2
30
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
16.6
26.7
43
30
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
26.5
25
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.7
25.3
57
79
L01BC06
ATC
capecitabine; oral
12.0
25.2
47
46
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
272.3
25.1
25
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.3
24.9
58
85
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
13.8
24.7
43
36
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
24.3
23
*
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
24.3
23
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.7
23.9
148
633
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
22.9
72
159
A09AA02
ATC
multienzymes (lipase, protease etc.)
20.1
22.8
34
19
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
237.0
21.9
22
*
JKA20
NOMESCO Finland
Cholecystectomy
12.0
21.7
40
38
C10AC01
ATC
colestyramine; oral
15.2
20.6
34
25
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
20.0
19
*
A04AA02
ATC
granisetron; systemic, transdermal
7.0
19.9
51
85
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
213.9
19.8
20
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
15.5
19.6
32
23
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
22.7
19.0
27
13
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.5
18.8
35
34
XX9AD
NOMESCO Finland
Complementary CT
+∞
17.9
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
17.4
125
562
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
16.8
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
16.8
75
232
JN4DD
NOMESCO Finland
Scout CT scan of torso
95.6
16.8
18
*
8249/3-C17.9
ICD-O-3
Neuroendocrine tumor, grade 2 of small intestine, NOS
179.8
16.7
17
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
16.6
127
590
N02AA05
ATC
oxycodone; systemic
3.7
15.8
79
268
8246/3-C17.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of small intestine, NOS
+∞
15.8
15
*
UJF32
NOMESCO Finland
Coloscopy
3.0
15.7
114
509
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
15.3
170
984
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
15.1
131
651
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
14.7
14
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
23.7
14.4
20
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.4
14.2
38
67
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
13.8
107
490
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
146.5
13.6
14
*
JFB20
NOMESCO Finland
Ileocaecal resection
25.7
12.6
17
7
2592A
ICD-9 Finland
Other endocrine disorders, Carcinoid syndrome
+∞
12.6
12
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.0
12.6
31
49
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
135.6
12.5
13
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.5
12.2
44
110
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
48.8
12.0
14
*
JAH00
NOMESCO Finland
Laparotomy
7.4
12.0
28
41
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.4
11.8
153
914
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
67.7
11.7
13
*
Z51.5
ICD-10 Finland
Palliative care
4.6
11.5
41
101
JN3AD
NOMESCO Finland
Abdominal CT examination
4.3
11.1
42
110
A55
ICPC
General and Unspecified, Local injection/infiltration
29.3
10.8
14
5
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
10.7
133
765
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
62.3
10.7
12
*
D76
ICPC
Malignant neoplasm pancreas
113.9
10.5
11
*
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
+∞
10.5
10
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
33.9
10.4
13
*
B03BA03
ATC
hydroxocobalamin; parenteral
4.7
10.2
35
83
A79
ICPC
Malignancy NOS
10.6
10.2
19
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
10.0
37
95
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
15.7
9.6
15
10
JF1BD
NOMESCO Finland
Very extensive small bowel CT
18.3
9.5
14
8
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
9.4
9
*
E340, C179
ICD-10 Finland
NA
+∞
9.4
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.2
9.4
17
16
R11
ICD-10 Finland
Nausea and vomiting
4.1
9.3
36
96
JAH01
NOMESCO Finland
Laparoscopy
6.1
9.1
24
42
ZXD05
NOMESCO Finland
Urgent procedure
2.3
9.1
109
606
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
19.4
9.0
13
7
B01AB10
ATC
tinzaparin; parenteral
3.7
8.8
38
112
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
51.6
8.7
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.5
8.7
25
49
A02BC05
ATC
esomeprazole; systemic
2.1
8.6
132
814
J01MA12
ATC
levofloxacin; systemic
2.6
8.6
72
330
L01CB01
ATC
etoposide; systemic
28.5
8.5
11
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
8.5
29
69
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
13.3
8.5
14
11
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
+∞
8.4
8
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
8.5
8.2
17
21
JJB10
NOMESCO Finland
Atypcal resection of liver
34.4
8.1
10
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
34.4
8.1
10
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
8.0
73
349
A50
ICPC
General and Unspecified, Medication/prescr/renewal
6.4
8.0
20
33
107
Kela drug reimbursment
Pernicious anaemia
8.1
8.0
17
22
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
7.9
61
269
Z51.88
ICD-10 Finland
Other specified medical care
9.8
7.9
15
16
158
Kela drug reimbursment
Everolimus
46.2
7.8
9
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.4
7.7
16
20
JLC30
NOMESCO Finland
Pancreatoduodenectomy
19.0
7.7
11
6
SPAT1254
SPAT
Administration of medicine
2.6
7.6
57
248
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
82.1
7.5
8
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
+∞
7.3
7
*
1522B
ICD-9 Finland
Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]
+∞
7.3
7
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
7.3
7
*
L01XE10
ATC
[U] everolimus; oral
+∞
7.3
7
*
L03AA04
ATC
NA
+∞
7.3
7
*
A04AA01
ATC
ondansetron; systemic, rectal
3.7
7.3
31
91
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
16.3
7.3
11
7
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
30.8
7.2
9
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.2
7.1
37
128
R4190
NOMESCO Finland
Nutritional therapy
5.1
7.0
21
44
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
6.4
6.9
17
28
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
23.1
6.7
9
*
-55
ICPC
Local injection/infiltration
23.1
6.7
9
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
8.1
6.7
14
18
-50
ICPC
Medication/prescr/renewal
3.9
6.7
26
71
B81
ICPC
Anaemia vit B12/folate deficiency
4.4
6.7
23
56
D75
ICPC
Malignant neoplasm colon/rectum
12.6
6.6
11
9
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
6.6
39
147
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
6.5
78
424
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
71.3
6.5
7
*
340
Kela drug reimbursment
Everolimus
71.3
6.5
7
*
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
9.6
6.3
12
13
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
6.3
6
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
+∞
6.3
6
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
6.3
6
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
6.3
6
*
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
6.3
6
*
JN5SR
NOMESCO Finland
Very extensive PET-CT of receptors in upper body
+∞
6.3
6
*
1CB02
NOMESCO Finland
NA
+∞
6.3
6
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
6.3
6
*
WZC30
NOMESCO Finland
Teaching
2.4
6.3
52
238
JJA20
NOMESCO Finland
Open biopsy of liver
27.3
6.3
8
*
UJF92
NOMESCO Finland
Capsular endoscopy
6.5
6.2
15
24
B01AB05
ATC
enoxaparin; parenteral
1.9
6.2
107
671
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
7.9
6.2
13
17
ZX120
NOMESCO Finland
Intravenous
2.8
6.1
39
153
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
12.9
6.1
10
8
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
10.3
6.1
11
11
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.1
6.0
22
57
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
234
32
281.49
307.65
11.1
2.6
nmol/l
21.0
8.7
0.95
229
32
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
216
12
570.55
307.65
10.2
3.2
nmol/l
381.6
60.5
8.06
216
12
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
65
43
18.79
76.45
4.4
1.7
ug/l
24.7
16.4
1.06
65
43
(4035726)
103
240
5.89
44.49
1.5
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
55
75
8.67
39.48
1.5
1.4
ug/g
237.0
273.0
0.55
40
43
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
101
272
4.99
36.21
2.3
2.3
g/l
0.2
0.2
1.19
96
254
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
104
331
4.20
29.41
3.6
4.3
ug/l
12.9
40.5
0.61
83
283
(3015377) Calcium [Moles/volume] in Serum or Plasma
193
934
3.75
29.17
8.5
3.5
mmol/l
2.3
2.3
0.25
183
810
(3024561) Albumin [Mass/volume] in Serum or Plasma
218
1196
3.67
25.97
8.9
5.0
g/l
35.7
35.4
0.48
212
1125
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
75
229
3.99
21.90
4.0
2.9
ng/l
97.0
188.3
3.01
67
204
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
175
911
3.07
21.32
4.9
3.1
ng/l
886.4
1295.4
1.42
161
791
(3013650) Neutrophils [#/volume] in Blood by Automated count
241
1526
3.47
20.43
18.8
9.5
e9/l
3.5
4.1
3.81
224
1337
(42870588) Differential panel, method unspecified - Blood
167
879
2.92
19.41
11.0
5.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
212
1271
3.04
19.28
6.8
6.2
mmol/l
1.2
1.2
0.63
197
1132
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
223
1378
3.12
19.13
7.8
7.0
mmol/l
1.2
1.2
0.02
165
1159
(3022096) Basophils/100 leukocytes in Blood
200
1170
2.94
18.88
10.7
5.7
%
0.7
0.6
1.37
192
1087
(3006504) Eosinophils/100 leukocytes in Blood
201
1205
2.85
17.66
10.8
5.7
%
3.2
2.9
0.75
193
1120
(3002030) Lymphocytes/100 leukocytes in Blood
204
1236
2.85
17.50
11.1
5.9
%
25.7
27.0
0.98
197
1145
(3019069) Monocytes/100 leukocytes in Blood
201
1210
2.83
17.43
11.2
6.1
%
10.0
8.8
5.83
193
1129
(3018010) Neutrophils/100 leukocytes in Blood
198
1217
2.69
15.91
11.0
5.7
%
58.3
57.6
0.31
191
1137
(3018418) pH of Serum or Plasma
153
849
2.56
14.92
5.8
3.7
ph
7.4
7.4
0.99
58
157
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
235
1645
2.69
13.34
6.0
3.3
u/l
77.1
52.0
2.03
226
1522
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
372
2.76
13.20
2.4
2.3
%
21.4
22.1
0.17
76
322
(3013115) Eosinophils [#/volume] in Blood
203
1336
2.46
13.01
11.1
5.8
e9/l
0.2
0.2
0.26
179
1177
(40768441) Liver Pathology biopsy report
17
21
8.50
12.87
1.1
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
198
1296
2.42
12.74
10.9
5.6
e9/l
0.0
0.0
0.86
178
1121
(3019198) Lymphocytes [#/volume] in Blood
200
1316
2.42
12.70
11.1
5.6
e9/l
1.6
1.9
0.76
179
1166
(3032080) INR in Blood by Coagulation assay
185
1178
2.38
12.64
10.8
9.0
inr
1.2
1.3
0.50
78
341
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
150
876
2.36
12.47
3.5
2.6
u/l
50.1
58.0
2.34
138
807
(3001604) Monocytes [#/volume] in Blood
196
1291
2.37
12.23
11.0
5.5
e9/l
0.6
0.6
0.15
177
1108
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
61
235
2.98
11.91
5.4
3.6
mmol/l
1.2
1.2
0.74
61
199
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
144
849
2.28
11.46
4.0
3.6
u/l
31.4
32.3
0.16
138
809
(3021589) Normoblasts [#/volume] in Blood
179
1167
2.24
11.00
22.4
10.0
e9/l
0.0
0.0
0.25
160
961
(3012095) Magnesium [Moles/volume] in Serum or Plasma
90
446
2.43
10.57
3.3
3.6
mmol/l
0.8
0.8
0.80
85
419
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
10
0
+∞
10.47
2.3
0.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
51
191
2.99
10.41
1.7
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
118
662
2.25
10.36
2.2
2.0
mg/l
3.1
3.2
0.13
99
576
(40758558) Short blood count panel - Blood
118
666
2.23
10.18
14.7
6.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
87
432
2.40
10.13
2.4
2.3
umol/l
12.5
12.7
0.11
81
400
(3035637) Corticotropin [Mass/volume] in Plasma
13
16
8.43
9.80
2.5
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
232
2.72
9.46
3.7
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
103
574
2.18
8.98
3.0
2.8
mosm/kgh2o
563.3
556.6
0.10
96
480
(40768804) Tissue Pathology biopsy report
157
1049
1.99
8.21
2.3
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
68
330
2.35
8.19
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
125
774
2.02
8.09
5.7
4.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
135
861
1.99
8.02
3.0
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
104
615
2.03
7.56
3.0
2.5
e6/l
4.2
4.4
0.08
97
537
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
62
303
2.30
7.30
4.5
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
154
1061
1.88
7.01
3.2
2.2
nmol/l
70.4
76.9
1.90
139
924
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
48
4.15
7.00
3.3
3.5
%
56.1
59.0
0.34
19
48
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
61
306
2.23
6.73
2.4
3.2
umol/l
9.0
9.2
0.02
53
276
(3002582) Erythrocytes [#/volume] in Urine
131
868
1.87
6.65
3.6
3.2
e6/l
44.8
125.2
0.52
109
673
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
46
4.09
6.53
2.9
2.9
e9/l
4.0
4.8
0.93
18
46
(3019225) pH of Specimen
54
262
2.28
6.43
4.5
3.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
119
773
1.87
6.37
3.6
3.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
27
4.98
6.03
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
62
328
2.11
5.95
2.2
2.8
%
1.8
1.8
0.22
54
299
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
51
250
2.24
5.92
2.3
2.6
u/l
31.1
32.0
0.05
46
214
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
25
4.95
5.54
1.3
1.2
nmol/l
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
52
3.61
5.54
2.3
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
367
2.01
5.52
1.9
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
119
807
1.76
5.34
3.3
3.1
e6/l
0.3
0.5
0.97
100
604
(3013512) EKG study
125
861
1.75
5.30
3.7
4.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
75
3.08
5.26
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
609
1.80
5.13
2.1
1.8
pmol/l
124051072.7
8000442.3
0.45
79
500
(40767503) Oxygen content in Capillary blood by calculation
18
55
3.41
5.11
1.3
2.2
%
14.0
15.5
—
8
24
(3031040) Bacteria [#/volume] in Urine by Automated count
218
1763
1.77
5.10
5.5
4.5
e6/l
544.8
2372.7
—
6
33
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
1238
1.70
5.06
5.0
4.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
138
993
1.69
4.91
4.3
3.7
e6/l
103.1
90.1
0.08
112
726
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
63
3.15
4.76
1.1
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
142
1037
1.67
4.73
3.0
2.6
ug/l
179.0
142.9
0.83
133
944
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
57
319
1.96
4.65
3.0
4.5
u/l
216.9
255.5
2.08
51
300
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
234
1954
1.77
4.65
4.7
3.7
pmol/l
14.5
14.9
1.73
214
1718
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
142
1044
1.66
4.56
3.4
3.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
21
4.89
4.56
1.5
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
140
2.26
3.91
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
148
1138
1.57
3.74
2.4
2.0
pmol/l
91.2
96.7
0.65
95
590
(4034850)
0
92
0.00
3.54
0.0
9.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
88
2.49
3.47
2.3
2.7
u/ml
0.3
0.3
0.19
12
41
(3023520) Reticulocytes [#/volume] in Blood
44
252
1.87
3.34
2.2
2.9
e9/l
64.6
71.0
0.58
29
201
(3022145) Colonoscopy Study observation
53
323
1.77
3.30
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
32
166
2.03
3.23
2.3
3.8
mmol/l
1.2
1.9
0.30
22
129
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
275
2494
1.81
3.11
32.5
14.5
ml/min/173m2
76.1
76.8
0.26
264
2065
(3041096) Erythrocytes [Presence] in Urine by Automated
99
719
1.55
3.11
4.2
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
51
2.83
3.02
1.5
2.5
—
—
—
0
0
(3009343) pH of Capillary blood
33
179
1.94
2.96
2.5
3.7
ph
7.4
7.4
—
7
17
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
284
2612
1.89
2.90
29.1
15.4
mg/l
27.4
24.4
0.74
252
2072
(3037467) Urinalysis macro (dipstick) panel - Urine
214
1842
1.50
2.86
4.5
4.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
36
3.13
2.83
1.2
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
33
184
1.89
2.74
2.5
3.6
kpa
5.2
5.1
0.36
33
170
(3028626) Oxygen [Partial pressure] in Capillary blood
16
67
2.46
2.68
1.9
2.6
kpa
8.3
7.8
0.32
16
60
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
245
2662
0.64
2.59
4.6
5.4
mmol/l
2.4
2.7
3.27
214
2422
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
650
1.49
2.49
2.9
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
110
850
1.45
2.48
3.7
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
451
1.56
2.46
2.8
3.1
e6/l
3.0
2.3
0.19
38
253
(3021960) Folate [Moles/volume] in Serum or Plasma
92
688
1.48
2.45
1.7
1.6
nmol/l
21.2
20.9
0.06
80
572
(3016244) Insulin [Units/volume] in Serum or Plasma
6
12
5.07
2.41
2.7
2.3
mu/l
7.5
8.1
—
6
12
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
12
5.07
2.41
2.8
1.8
umol/l
27.7
28.0
—
6
12
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
85
2.19
2.33
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
64
449
1.53
2.30
1.7
1.8
—
—
—
0
0
(4281824)
8
23
3.54
2.28
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
31
2.96
2.09
1.3
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
31
2.96
2.09
5.4
8.4
mmol/l
6.5
6.3
—
9
26
(3004451) EKG impression Narrative
7
20
3.55
2.06
1.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
38
2.69
2.03
1.4
1.7
%
90.7
89.5
—
10
38
(3002179) Metamyelocytes/100 leukocytes in Blood
32
195
1.71
2.02
2.4
4.2
%
0.6
0.4
—
5
53
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
230
2500
0.70
1.98
3.8
4.3
mmol/l
1.3
1.3
0.64
196
2258
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
241
2598
0.69
1.97
4.3
4.8
mmol/l
4.3
4.6
2.54
208
2380
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
239
2580
0.69
1.96
4.3
4.7
mmol/l
1.4
1.5
0.15
208
2344
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
27
3.01
1.95
1.5
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
11
4.60
1.95
2.0
1.5
ug/l
51.4
72.5
—
5
11
(3021440) Promyelocytes/100 leukocytes in Blood
33
206
1.67
1.92
2.4
4.3
%
0.1
0.1
—
8
70
(3019309) Folate [Moles/volume] in Red Blood Cells
73
547
1.44
1.89
2.2
1.7
nmol/l
1529.4
1226.3
1.15
48
405
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
1136
1.35
1.83
4.2
3.9
ng/l
44.2
36.8
0.13
110
870
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
23
3.09
1.81
1.4
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
42
596
0.66
1.74
4.0
4.1
kg/l
1.0
1.0
0.38
11
90
(3044889) 12 lead EKG panel
216
1942
1.36
1.73
5.8
4.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
58
423
1.45
1.73
1.7
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
14
3.61
1.62
1.4
5.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
43
2.37
1.62
2.7
2.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
158
0.43
1.60
3.3
2.8
%
1.0
1.3
—
7
158
(3035880) pH of Pleural fluid
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(4062490)
6
20
3.04
1.59
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
194
1.60
1.55
2.5
4.4
%
0.9
0.1
—
7
61
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
44
2.31
1.55
1.3
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
46
617
0.70
1.41
3.0
3.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
46
2.21
1.41
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
46
2.21
1.41
1.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
33
224
1.53
1.40
2.4
4.2
%
0.9
0.8
—
7
79
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
255
2383
1.37
1.38
5.5
4.6
mu/l
1.8
2.0
1.07
233
2125
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
156
1369
1.28
1.35
2.2
2.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
62
1.97
1.29
5.1
4.5
mg/l
32.2
32.0
—
6
37
(3009542) Hematocrit [Volume Fraction] of Blood
244
2275
1.32
1.26
27.4
17.0
%
38.2
39.7
1.81
170
1537
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
49
2.07
1.23
1.2
7.9
—
146.4
—
0
8
(3013707) Erythrocyte sedimentation rate by Westergren method
213
1955
1.28
1.22
3.7
4.1
mm/h
16.1
12.9
1.66
192
1777
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
65
516
1.33
1.19
1.2
1.2
u/ml
0.6
1.5
1.26
15
137
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
111
0.44
1.15
2.0
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
89
741
1.28
1.15
4.0
4.2
estimate
0.0
0.0
0.00
59
249
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
492
1.32
1.14
2.7
2.9
e6/l
0.9
1.0
0.18
36
290
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
16
96
1.70
1.12
1.2
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
51
1.99
1.12
2.8
3.3
u/ml
14.5
31.0
—
10
51
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
22
144
1.57
1.12
8.4
11.8
mmol/l
24.3
24.8
0.26
22
136
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
66
1.85
1.10
1.3
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
32
2.21
1.08
3.0
3.2
—
—
—
0
0
(4306422)
7
32
2.21
1.08
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
36
264
1.41
1.08
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
52
1.95
1.07
1.5
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
68
553
1.29
1.05
3.8
5.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
49
1.86
0.99
1.3
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
36
1.97
0.97
2.0
2.0
pg
30.4
33.4
—
7
36
(3009508) Creatinine [Moles/volume] in Urine
101
872
1.23
0.95
2.9
3.1
mmol/l
6.6
7.5
1.69
84
713
(3037756) Immunofixation for Serum or Plasma
12
70
1.74
0.94
1.8
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
143
1.50
0.92
3.1
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
885
0.80
0.92
3.7
4.6
%
23.0
21.1
0.57
37
449
(40761535) Cells panel - Urine sediment
16
240
0.65
0.90
2.1
3.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
95
1.61
0.89
1.8
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
56
1.81
0.89
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
24
170
1.45
0.88
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
64
1.74
0.87
4.1
4.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
88
1.62
0.86
2.8
3.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
45
1.80
0.85
1.6
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
32
1.89
0.82
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
175
0.62
0.81
1.6
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
98
1.56
0.80
3.7
3.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
262
2510
1.26
0.79
8.6
6.3
mmol/mol
41.2
40.5
0.64
246
2316
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
253.4
—
0
14
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.0
—
36.2
—
0
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
555.6
—
0
15
(3028026) IgM [Mass/volume] in Serum or Plasma
24
174
1.41
0.79
1.8
1.8
g/l
1.1
1.5
0.67
18
156
(3045142) Bone marrow Pathology biopsy report
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
25
0.00
0.79
0.0
2.6
—
504.1
—
0
15
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
67
1.67
0.76
1.3
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
54
1.69
0.75
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
24
2.10
0.75
2.6
3.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
364
1.28
0.74
4.1
4.8
%
33.6
31.7
0.53
31
240
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
25
2.02
0.73
1.2
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
40
1.77
0.71
1.6
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.1
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
168
0.64
0.69
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
180
1.36
0.67
2.5
3.0
e9/l
3.5
3.9
0.47
18
136
(3042631) Mycobacterium sp identified in Specimen
7
43
1.64
0.67
4.6
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
103
1.48
0.66
1.9
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
279
1.29
0.66
2.2
2.3
ug/g
100.1
131.9
0.70
29
224
(1761868) Lipid panel - Serum or Plasma
75
856
0.84
0.65
3.2
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
279
2707
1.27
0.64
27.1
14.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
29
1.74
0.64
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
29
1.74
0.64
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
101
0.59
0.63
1.0
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
71
1.57
0.63
1.1
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
137
0.65
0.62
1.2
1.3
—
—
—
0
0
(4146454)
5
30
1.68
0.61
1.6
2.6
—
—
—
0
0
(4268621)
5
30
1.68
0.61
2.8
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
51
1.58
0.61
1.1
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
0
20
0.00
0.60
0.0
2.6
—
488.9
—
0
14
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
55.5
—
0
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
352
0.78
0.60
9.5
7.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
89
1.48
0.59
1.5
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
35
1.73
0.58
5.7
3.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
99
1093
0.86
0.57
4.7
5.2
ug/l
1.8
2.7
1.63
88
976
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
86
0.57
0.57
1.2
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
36
1.68
0.57
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
37
1.63
0.56
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
37
1.63
0.56
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
37
1.63
0.56
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
37
1.63
0.56
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
38
1.59
0.54
1.7
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
38
1.59
0.54
1.3
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
39
1.55
0.53
1.5
3.3
—
1265.4
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
109
1.39
0.52
1.1
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
109
1.39
0.52
3.7
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
65
1.40
0.51
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
318
1.22
0.50
1.6
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
61
535
1.17
0.49
2.7
3.7
ng/l
101.2
262.9
0.97
52
442
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
319
1.22
0.49
1.6
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
565
1.17
0.48
1.7
1.8
mg/l
1.7
1.4
0.45
46
455
(3007164) IgA [Mass/volume] in Serum or Plasma
56
489
1.18
0.48
1.5
1.4
g/l
2.3
2.7
0.55
30
287
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
246
1.24
0.47
1.3
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
142
0.69
0.47
1.0
1.3
—
59.2
—
0
10
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
330
1.21
0.47
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
121
1.34
0.45
1.1
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
239
1.24
0.44
8.8
9.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
128
0.69
0.44
1.8
1.2
u/ml
59.2
197.8
—
9
115
(3021601) Nitrite [Presence] in Urine by Test strip
141
1321
1.12
0.44
5.5
5.1
estimate
0.0
0.0
0.00
61
255
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
285
2792
1.22
0.43
25.2
11.2
u/l
27.7
25.4
1.54
279
2682
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
0.1
—
0
10
(3015183) Erythrocyte sedimentation rate
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(44806420)
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
335
1.19
0.41
5.8
9.5
mmol/l
0.9
1.4
0.30
32
270
(3050129) First trimester maternal screen panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
160
0.74
0.41
1.8
2.5
—
12.1
—
0
7
(40768793) Breast Pathology biopsy report
8
60
1.34
0.40
1.4
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
34
1.48
0.40
3.0
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
7
101
0.69
0.40
1.1
2.0
ug/l
253.6
293.3
—
7
94
(3035320) C reactive protein [Mass/volume] in Body fluid
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
61
1.32
0.40
1.1
1.1
—
14.8
—
0
7
(3035350) Ketones [Presence] in Urine by Test strip
139
1308
1.11
0.39
3.8
3.8
estimate
0.0
0.0
0.00
63
255
(3017704) Immunofixation for Urine
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
111
1037
1.11
0.36
4.4
4.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
42
1.44
0.35
1.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
43
1.40
0.35
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
43
1.40
0.35
2.5
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
62
683
0.89
0.34
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
256
1.19
0.34
1.6
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
92
854
1.11
0.33
2.8
3.2
mg/l
36.6
276.3
1.14
52
555
(3009261) Glucose [Presence] in Urine by Test strip
141
1338
1.10
0.33
4.1
3.9
estimate
0.0
0.0
0.00
65
244
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
355
1.15
0.30
1.1
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
57
1.23
0.29
1.7
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
86
1.29
0.26
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
87
1.27
0.24
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
157
0.82
0.23
3.4
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
88
1.26
0.23
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
92
0.76
0.23
1.0
1.2
—
3.8
—
0
7
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
79
1.27
0.22
1.5
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
40
1.25
0.22
3.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
290
2867
1.15
0.22
43.6
22.8
e12/l
4.3
4.5
9.66
285
2784
(3000963) Hemoglobin [Mass/volume] in Blood
290
2867
1.15
0.22
43.9
22.9
g/l
127.9
135.5
12.91
285
2818
(3028300) Cannabinoids [Presence] in Urine
5
41
1.22
0.22
3.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
41
1.22
0.22
3.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
41
1.22
0.22
3.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
124
0.80
0.22
1.3
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
46
422
1.11
0.22
1.2
1.3
iu/ml
13.7
41.4
3.37
18
124
(3027944) Amphetamines [Presence] in Urine
5
42
1.19
0.21
3.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
14.7
—
860.4
—
0
11
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
18.2
—
1363.2
—
0
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
9.6
—
0
11
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
57.9
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.2
—
8.1
—
0
12
(44813793)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
13
0.00
0.21
0.0
1.1
—
2.3
—
0
13
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
112
0.80
0.20
1.1
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
14
0.00
0.20
0.0
2.5
—
13.6
—
0
14
(4027681)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
1.1
—
0
9
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
14
0.00
0.20
0.0
1.4
—
23.3
—
0
9
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.7
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
147
1.17
0.18
2.2
2.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
40
368
1.10
0.18
30.7
22.6
inr
1.3
1.3
—
8
49
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
60
1.17
0.18
1.0
1.2
—
1.0
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
63
1.11
0.17
1.9
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
70
1.15
0.16
1.8
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
15
130
1.16
0.16
5.5
4.2
mmol/l
22.8
24.4
1.11
15
119
(1002224) Polysomnography panel
7
86
0.81
0.14
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
74
707
1.06
0.14
3.1
2.8
umol/l
376.6
9653.5
3.92
68
597
(3020682) Albumin/Creatinine [Ratio] in Urine
94
905
1.06
0.14
3.8
4.0
mg/mmol
9.5
7.6
0.13
55
575
(3049717) Cytology report of Urine Cyto stain
15
133
1.13
0.12
4.1
2.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
404
0.93
0.12
1.2
1.2
u/ml
1.6
13.9
2.17
15
152
(3004588) Protein electrophoresis panel - Serum or Plasma
22
201
1.10
0.11
3.3
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
77
747
1.04
0.08
1.6
1.7
mmol/l
1.4
1.3
0.75
61
610
(3045414) Leukocytes [Presence] in Urine
10
113
0.88
0.08
1.6
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
58
1.04
0.08
3.0
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
62
0.80
0.08
1.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
156
1.09
0.08
9.1
13.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
61
631
0.96
0.08
3.2
3.1
ug/l
0.7
0.8
0.21
42
428
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
66
1.06
0.08
1.0
1.3
—
2.8
—
0
11
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
258
2600
0.96
0.08
6.9
4.9
mmol/l
6.4
6.1
3.40
241
2347
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
166
1.09
0.08
1.7
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
68
1.03
0.08
1.0
1.3
—
1.9
—
0
11
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
76
1.05
0.07
1.6
1.4
—
—
—
0
0
(4094501)
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
91
0.88
0.07
1.6
1.6
—
163.3
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
8
91
0.88
0.07
4.6
4.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
193
0.93
0.06
2.7
6.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
152
0.92
0.06
1.1
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
199
1.06
0.04
5.8
2.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
270
0.96
0.03
4.6
4.0
mmol/l
1.4
2.1
0.29
19
218
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
161
1.06
0.03
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
22
229
0.96
0.03
1.2
1.5
—
—
—
0
0
(3012544) pH of Venous blood
29
281
1.04
0.02
4.3
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
178
0.95
0.02
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
283
1.03
0.01
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
316
0.98
0.00
2.0
1.6
—
—
—
0
0
(3020891) Body temperature
12
121
0.99
0.00
2.9
3.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
124
0.97
0.00
1.7
1.3
—
—
—
0
0
(4010399)
20
204
0.98
0.00
1.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
304
0.99
0.00
1.4
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
33
330
1.00
0.00
1.4
1.3
titre
756.4
521.8
0.21
11
66
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
61
0.98
0.00
1.5
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
66
0.91
0.00
1.5
2.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
12.6
—
0
5
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
114.2
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
81
0.99
0.00
1.3
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.3
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
15.4
—
7.4
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
57
0.88
0.00
1.4
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
64
0.94
0.00
1.7
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_CARCISDR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_CARCISDR | 4.015 [3.24, 4.98] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.136 |
During the follow-up period (1.1.1998 — 31.12.2019), 304 out of 704 females with E4_CARCISDR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_CARCISDR | 3.911 [3.06, 4.99] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.034 |
During the follow-up period (1.1.1998 — 31.12.2019), 305 out of 623 males with E4_CARCISDR died.
Mortality risk
Mortality risk for people of age
years, who have E4_CARCISDR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.313% | 0.692% |
| 5 | 2.093% | 4.777% |
| 10 | 5.068% | 11.321% |
| 15 | 9.75% | 20.778% |
| 20 | 16.571% | 33.927% |
Relationships between endpoints
↥Index endpoint: E4_CARCISDR – Carcinoid syndrome
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data